126 related articles for article (PubMed ID: 28222316)
1. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.
Horley NJ; Beresford KJ; Chawla T; McCann GJ; Ruparelia KC; Gatchie L; Sonawane VR; Williams IS; Tan HL; Joshi P; Bharate SS; Kumar V; Bharate SB; Chaudhuri B
Eur J Med Chem; 2017 Mar; 129():159-174. PubMed ID: 28222316
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.
Williams IS; Joshi P; Gatchie L; Sharma M; Satti NK; Vishwakarma RA; Chaudhuri B; Bharate SB
Bioorg Med Chem Lett; 2017 Aug; 27(16):3683-3687. PubMed ID: 28711350
[TBL] [Abstract][Full Text] [Related]
3. Biphenyl urea derivatives as selective CYP1B1 inhibitors.
Mohd Siddique MU; McCann GJ; Sonawane V; Horley N; Williams IS; Joshi P; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
Org Biomol Chem; 2016 Sep; 14(38):8931-8936. PubMed ID: 27714268
[TBL] [Abstract][Full Text] [Related]
4. Quinazoline derivatives as selective CYP1B1 inhibitors.
Mohd Siddique MU; McCann GJ; Sonawane VR; Horley N; Gatchie L; Joshi P; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
Eur J Med Chem; 2017 Apr; 130():320-327. PubMed ID: 28259840
[TBL] [Abstract][Full Text] [Related]
5. CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance.
Sonawane VR; Siddique MUM; Gatchie L; Williams IS; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
Eur J Pharm Sci; 2019 Apr; 131():177-194. PubMed ID: 30776468
[TBL] [Abstract][Full Text] [Related]
6. Identification of Potent and Selective CYP1A1 Inhibitors via Combined Ligand and Structure-Based Virtual Screening and Their in Vitro Validation in Sacchrosomes and Live Human Cells.
Joshi P; McCann GJP; Sonawane VR; Vishwakarma RA; Chaudhuri B; Bharate SB
J Chem Inf Model; 2017 Jun; 57(6):1309-1320. PubMed ID: 28489395
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.
Sharma R; Gatchie L; Williams IS; Jain SK; Vishwakarma RA; Chaudhuri B; Bharate SB
Bioorg Med Chem Lett; 2017 Dec; 27(24):5400-5403. PubMed ID: 29150398
[TBL] [Abstract][Full Text] [Related]
8. (E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent.
Horley NJ; Beresford KJM; Kaduskar S; Joshi P; McCann GJP; Ruparelia KC; Williams IS; Gatchie L; Sonawane VR; Bharate SB; Chaudhuri B
Bioorg Med Chem Lett; 2017 Dec; 27(24):5409-5414. PubMed ID: 29138024
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors.
Dong J; Wang Z; Cui J; Meng Q; Li S
Eur J Med Chem; 2020 Feb; 187():111938. PubMed ID: 31830634
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
[TBL] [Abstract][Full Text] [Related]
11. α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship.
Chen P; Wang S; Cao C; Ye W; Wang M; Zhou C; Chen W; Zhang X; Zhang K; Zhou W
Bioorg Chem; 2021 Nov; 116():105295. PubMed ID: 34455300
[TBL] [Abstract][Full Text] [Related]
12. Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors.
Dong J; Huang G; Cui Q; Meng Q; Li S; Cui J
Eur J Med Chem; 2021 Jan; 209():112895. PubMed ID: 33069055
[TBL] [Abstract][Full Text] [Related]
13. The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells.
Ruparelia KC; Zeka K; Ijaz T; Ankrett DN; Wilsher NE; Butler PC; Tan HL; Lodhi S; Bhambra AS; Potter GA; Arroo RRJ; Beresford KJM
Med Chem; 2018; 14(4):322-332. PubMed ID: 29332599
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
[TBL] [Abstract][Full Text] [Related]
15. A new class of CYP1B1 inhibitors derived from bentranil.
Yi L; Huang X; Yang M; Cai J; Jia J; Peng Z; Zhao Z; Yang F; Qiu D
Bioorg Med Chem Lett; 2023 Jan; 80():129112. PubMed ID: 36565966
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
17. Perspective of structural flexibility on selective inhibition towards CYP1B1 over CYP1A1 by α-naphthoflavone analogs.
Wang Y; Hu B; Zhang Y; Wang D; Luo Z; Wang J; Zhang F
Phys Chem Chem Phys; 2021 Sep; 23(36):20230-20246. PubMed ID: 34474468
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.
Zhou L; Chen W; Cao C; Shi Y; Ye W; Hu J; Wang L; Zhou W
Eur J Med Chem; 2020 Mar; 189():112028. PubMed ID: 31945665
[TBL] [Abstract][Full Text] [Related]
19. In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study.
Sharma H; Raju B; Narendra G; Kumar M; Verma H; Sharma B; Tung GK; Kumar Jain S; Brás NF; Silakari O
J Mol Graph Model; 2023 Mar; 119():108390. PubMed ID: 36502606
[TBL] [Abstract][Full Text] [Related]
20. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]